A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)

Henrik Lindman, Carl Blomqvist, Johan Ahlgren et al.|European Journal of Cancer|2018

Cited by 4